Get help selecting stem cells after poor transplant recovery
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial offers a specialized device to help choose certain stem cells after a transplant when graft function is poor or not working. It may help improve how well the transplant takes and functions in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a stem cell transplant (bone marrow transplant).
- After the transplant, your graft function is poor or not working.
- There are no listed exclusion conditions for this trial.
- You will likely need transplant-related medical records to confirm graft function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a lab-made cell treatment added around an allogeneic stem cell transplant (donor transplant). It tries to improve transplant safety and outcomes by removing certain immune cells from the donor stem cells.
This study tests whether giving extra stem cells from your original donor can help your blood cell counts recover after a transplant. It is for people whose new immune system has not fully engrafted or whose counts are dangerously low.
This trial tests whether a type of stem cell (mesenchymal stem cells) can help improve low blood cell counts after a donor stem cell transplant. It is for people whose counts are not recovering well.
This trial tests a machine that picks out healthy stem cells for a bone marrow transplant. It may help people with certain blood cancers or disorders get a transplant with fewer complications.
This study tests whether umbilical cord blood cells can help patients whose blood counts have dropped again after a stem cell transplant. It may be an option for people who have recovered initially but later develop low blood cell levels.
This Phase 2 study tests a specific type of donor stem cell transplant for severe bone marrow failure conditions, aiming to improve cure rates while reducing transplant risks. It includes people with diseases like severe aplastic anemia and certain bone marrow disorders, especially when standard transplant plans feel too risky.
Hear when a new Blood And Marrow Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.